Combined OX40L and mTOR Blockade Controls Effector T Cell Activation While Preserving T Reg Reconstitution After Transplant
Science Translational Medicine - United States
doi 10.1126/scitranslmed.aan3085
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 20, 2017
Authors
Publisher
American Association for the Advancement of Science (AAAS)